Structure Therapeutics (GPCR) just moved its obesity pipeline up a gear by kicking off a first in human Phase 1 trial for ACCG-2671, its oral amylin receptor agonist targeting metabolic disease. See ...
With the last Block 2 flight lifting off on Oct. 14th, 2025, SpaceX has no more need for Pad 1’s current infrastructure.
An update from Structural Monitoring Systems Shs Chess Depository Interests ( (AU:SMN)) is now available. Structural Monitoring Systems Plc has appointed experienced corporate adviser and chartered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback